XML 33 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The Chairman of the Board, President and Chief Executive Officer has been determined to be the Company’s Chief Operating Decision Maker and he uses Operating Profit to assess performance and to allocate resources for each of the reportable operating segments in the budgeting and forecasting process. Asset information by segment is not utilized for purposes of assessing performance or allocating resources, and therefore such information has not been presented.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
Corporate Operating profit (loss) for the nine months ended September 30, 2025 included a charge resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9.
Corporate Operating profit (loss) for the three and nine months ended September 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $15 and $77, respectively.
The Company’s net sales, significant segment expenses and operating profit, by reportable segment were:
Three Months Ended September 30, 2025
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (1)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America$999 $398 $401 $10 $190 
Latin America1,178 541 303 (2)337 
Europe801 300 285 7 209 
Asia Pacific714 270 264 (8)188 
Africa/Eurasia297 118 106 4 68 
Total Oral, Personal and Home Care3,989 992 
Pet Nutrition1,142 457 427 2 255 
Reconciliation with Total Company Operating Profit
Corporate(189)
Total$5,131 $1,059 
Note: Table may not sum due to rounding.
(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.

Nine Months Ended September 30, 2025
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (1)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America$3,024 $1,178 $1,233 $33 $580 
Latin America3,528 1,555 936 (15)1,052 
Europe2,228 832 811 20 566 
Asia Pacific2,092 796 746 (22)573 
Africa/Eurasia863 339 323 12 190 
Total Oral, Personal and Home Care11,735 2,961 
Pet Nutrition3,417 1,356 1,280 4 778 
Reconciliation with Total Company Operating Profit
Corporate(523)
Total$15,152 $3,214 
Note: Table may not sum due to rounding.
(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
Three months ended September 30, 2024
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (1)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America$1,004 $381 $409 $8 $206 
Latin America1,156 459 325 7 365 
Europe744 275 280 8 181 
Asia Pacific725 269 264 (8)199 
Africa/Eurasia278 109 99 5 65 
Total Oral, Personal and Home Care3,907 1,016 
Pet Nutrition1,126 463 406 (1)258 
Reconciliation with Total Company Operating Profit
Corporate(208)
Total$5,033 $1,065 
Note: Table may not sum due to rounding.
(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.

Nine Months Ended September 30, 2024
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (1)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America$3,076 $1,166 $1,254 $23 $633 
Latin America3,676 1,464 1,023 2 1,187 
Europe2,102 801 777 22 502 
Asia Pacific2,133 814 739 (21)602 
Africa/Eurasia827 319 301 12 195 
Total Oral, Personal and Home Care11,814 3,119 
Pet Nutrition3,342 1,404 1,239 9 691 
Reconciliation with Total Company Operating Profit
Corporate(605)
Total$15,156 $3,205 
Note: Table may not sum due to rounding.
(1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
Three Months EndedNine Months Ended
 September 30,September 30,
 2025202420252024
Net sales
Oral Care44 %44 %44 %43 %
Personal Care18 %18 %17 %18 %
Home Care16 %16 %16 %17 %
Pet Nutrition22 %22 %23 %22 %
Total Net sales100 %100 %100 %100 %

Capital expenditures and depreciation and amortization expense by segment were:
Three Months EndedNine Months Ended
 September 30,September 30,
 2025202420252024
Capital expenditures  
Oral, Personal and Home Care 
North America$18 $9 $48 $30 
Latin America46 34 96 80 
Europe18 13 38 33 
Asia Pacific17 22 49 41 
Africa/Eurasia4 3 8 6 
Total Oral, Personal and Home Care103 81 239 190 
Pet Nutrition21 24 64 108 
Corporate31 29 84 79 
Total Capital expenditures$155 $134 $387 $377 

Three Months EndedNine Months Ended
 September 30,September 30,
 2025202420252024
Depreciation and amortization  
Oral, Personal and Home Care 
North America$32 $30 $92 $93 
Latin America27 24 78 77 
Europe16 17 48 49 
Asia Pacific19 20 59 60 
Africa/Eurasia3 2 7 6 
Total Oral, Personal and Home Care97 93 284 285 
Pet Nutrition35 33 98 100 
Corporate26 24 75 72 
Total Depreciation and amortization$158 $150 $457 $457